The Future of NHS Right to Choose: What You Need to Know
Understanding NHS Right to Choose
The Right to Choose NHS is a fundamental aspect of healthcare in England, allowing patients to select their mental healthcare provider and the team responsible for their treatment. This right has been essential for those seeking timely ADHD assessment pathways and autism diagnosis pathways, as it enables them to bypass long waiting lists by choosing alternative NHS-funded providers.
However, significant changes are on the horizon that could dramatically alter the availability and accessibility of NHS ADHD diagnosis and other specialist referrals. If implemented, these changes may result in increased waiting times, fewer provider options, and a diminished ability to access private ADHD assessment through NHS funding.
Proposed Changes to NHS Right to Choose
New Restrictions on ADHD and Autism Assessments
NHS England is currently consulting on a change that would restrict patients’ ability to choose their ADHD and autism assessment provider. Under the proposed right to choose legislation, Integrated Care Boards (ICBs) will have greater control over when and where a patient can be seen, rather than allowing them to seek the earliest available ADHD treatment options.
- Current system: Patients can choose any NHS-approved provider that has capacity, significantly reducing wait times.
- Proposed system: Local ICBs will decide when a patient can be referred, likely extending waiting periods from months to years.
These changes will impact everyone relying on NHS-funded healthcare for ADHD and autism assessments, making private ADHD treatment the only viable option for many patients who cannot endure prolonged delays.
Impact on ADHD and Autism Services
The anticipated consequences of these changes include:
- Increased waiting times – Current NHS waits for ADHD assessment already exceed 10 years in some regions. Without Right to Choose, these times will worsen.
- Limited provider options – Many providers who currently offer NHS autism assessments and ADHD medication for adults and children may be excluded from the new system.
- Service disruptions – Those already in treatment under Right to Choose ADHD pathways may have their care discontinued if funding is withdrawn.
What This Means for ADHD Patients
If these changes are implemented, the ability to seek an ADHD assessment pathway outside of one’s local NHS region will be severely restricted. Patients who would have previously been referred for private ADHD assessment under NHS funding will now face extensive waiting lists in their area, forcing many to seek private ADHD treatment directly.
Additionally, ADHD medication for children and adults could become harder to obtain due to reductions in available services. Those who rely on annual medication reviews may find their prescriptions delayed or discontinued due to provider constraints.
Book a Private ADHD Assessment to skip the NHS waiting lines
How to Take Action
Protest the Change
The public consultation on these changes closes at the end of February, with implementation expected by April 1st. Since individuals are not allowed to formally respond, the most effective way to prevent this restriction is by contacting your MP.
- Email your MP to express concern over these changes and their impact on NHS specialist referrals.
- Raise awareness through social media and community groups about the proposed restrictions on right to choose frameworks.
- Join advocacy groups fighting against these NHS policy changes.
Frequently Asked Questions
1. How does the NHS Right to Choose work for ADHD assessments?
The NHS Right to Choose allows patients to select an approved provider for ADHD diagnosis and treatment, reducing long waiting times associated with local NHS services.
2. Will my current Right to Choose ADHD treatment be affected?
If the changes proceed, many patients receiving ADHD medication for adults and children through Right to Choose providers could see their services discontinued or restricted.
3. What can I do to stop this change?
Write to your MP, share awareness through social media, and advocate for continued patient choice in NHS-funded healthcare.
.svg)
.svg)
